Sistema de Información Esencial en Terapéutica y Salud


Última actualización: 17/8/2017
SIETES contiene 91969 citas

 1 a 20 de 211 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
Dimmitt S, Stampfer H, Martin JH. When less is more – Efficacy with less toxicity at the ED50. Br J Clin Pharmacol 2017;83:1365-8. [Ref.ID 101984]
2. Cita con resumen
Anónimo. Eli Lilly ends development of experimental heart drug. DIA Daily 2016:13 de octubre. [Ref.ID 99559]
3.Tiene citas relacionadas Cita con resumen
The HPS2-THRIVE Collaborative Group. Effects of extended-release niacin with laropiprant in high-risk patients. N Engl J Med 2014;371:203-12. [Ref.ID 97194]
4. Cita con resumen
Hiatt WR, Smith RJ. Assessing the clinical benefits of lipid-disorder. N Engl J Med 2014;370:396-9. [Ref.ID 97063]
5.Tiene citas relacionadas Cita con resumen
Martin SS, Blaha MJ, Elshazly MB, Toth PP, Kwiterovich PO, Blumenthal RS, Jones SR. Comparison of a novel method vs the Friedewald equation for estimating low-density lipoprotein cholesterol levels from the standard lipid profile. JAMA 2013;310:2061-8. [Ref.ID 96573]
6.Tiene citas relacionadas Cita con resumen
Gaziano JM, Gaziano TA. What's new with measuring cholesterol?. JAMA 2013;310:2043-944. [Ref.ID 96571]
Schwartz GG, Olsson AG, Abt M, Mallantyne CM, Barter PJ, Brumm J, Chatman BR, Holme IM, Kallend D, Leiter LA, Leitersdorf E, McMurray JJV, Mundi H, Nicholis SJ, Shah PK, Tardif JC, Wright RS, for the dal-OUTCOMES Investigators. Effects of dalcetrapib in patients with a recent acute coronary syndrome. N Engl J Med 2012;367:2089-99. [Ref.ID 94165]
9. Cita con resumen
Boekholdt SM, Arsenault BJ, Mora S, Pedersen TR, LaRosa JC, Nestel PJ, Simes RJ, Durrington P, Hitman GA, Welch KMA, DeMicco DA, Zwinderman AH, Clearfield MB, Downs JR, Tonkin AM, Colhoun HM, Gotto Jr AM, Ridker PM, Kastelein JJP. Association of LDL cholesterol, non-HDL cholesterol, and apolipoprotein B levels with risk of cardiovascular events among patients treated with statins: a meta-analysis. JAMA 2012;307:1302-9. [Ref.ID 92568]
10.Tiene citas relacionadas Cita con resumen
Niessen SE. Pharmacogenomics and clopidogrel: irrational exuberance?. JAMA 2011;306:2727-8. [Ref.ID 91942]
12.Tiene citas relacionadas
Anónimo. Why do the results of randomised and observational studies differ?. BMJ 2011;343:1128. [Ref.ID 91915]
13.Tiene citas relacionadas
Cannon CP. High-density lipoprotein cholesterol as the holy grail. JAMA 2011;306:2153-5. [Ref.ID 91827]
14.Tiene citas relacionadas Cita con resumen
Nicholls SJ, Brewer HB, Kastelein JJP, Krueger KA, Wang MD, Shao M, Hu B, McErlean E, Nissen SE. Effects of the CETP inhibitor evacetrapib administered as monotherapy or in combination with statins on HDL and LDL cholesterol: a randomized controlled trial. JAMA 2011;306:2099-109. [Ref.ID 91826]
15.Tiene citas relacionadas Cita con resumen
Fayad ZA, Mani V, Woodward M, Kallend D, Abt M, Burgess T, Fuster V, Ballantyne CM, Stein EA, Tardiff CM, Rudd JHF, Farkouh ME, Tawakol A, for the dal-PLAQUE Investigators. Safety and efficacy of dalcetrapib on atherosclerotic disease using novel non-invasive multimodality imaging (dal-PLAQUE): a randomised clinical trial. Lancet 2011;378:1547-59. [Ref.ID 91765]
16.Tiene citas relacionadas Cita con resumen
Stroes ESG, van Wijk DF. Dalcetrapib: turning the tide for CETP inhibition?. Lancet 2011;378:1529. [Ref.ID 91763]
17.Tiene citas relacionadas
Nicholls SJ, Ballantyne CM, Barter PJ, Chapman MJ, Erbel RM, Libby P, Raichlen JS, Uno K, Borgman M, Wolski K, Nissen SE. Effect of two intensive statins regimens on progression of coronary disease. N Engl J Med 2011;365:2078-87. [Ref.ID 91621]
18.Tiene citas relacionadas Cita con resumen
Giugliano RP. Niacin at 56 years of age - Time for an early retirement?. N Engl J Med 2011;365:2318-20. [Ref.ID 91618]
19.Tiene citas relacionadas Cita con resumen
The AIM-HIGH Investigators. Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy. N Engl J Med 2011;365:2255-67. [Ref.ID 91616]
20.Enlace a cita original Cita con resumen
Newson RS, Felix JF, Heeringa J, Hofman A, Witteman JCM, Tiemeier H. Association between serum cholesterol and noncardiovascular mortality in older age. American Geriatris Society 2011;59:1779-85. [Ref.ID 91593]
Seleccionar todas
 1 a 20 de 211 siguiente >>